Therapeutic Areas

IXICO's team of scientists, researchers, global operations and regulatory specialists works across a spectrum of neurological conditions to provide insight and support delivery of your clinical programme.

We are recognised internationally as experts in neuroscience data management and analysis. Since 2004, our technology and scientific expertise have been selected to support clinical trials for the majority of the top pharmaceutical and speciality biotechnology companies.

Read more about some of the neurological conditions we cover below, and see how we help monitor for progressive multifocal leukoencephalopathy (PML) here.

Alzheimer's Disease

IXICO has supported important Alzheimer's Disease research since 2007. We have provided imaging biomarkers for over 70 clinical studies in neuroscience, of which, over 30 have been in Alzheimer's disease.

Read more

Parkinson's Disease

IXICO first supported a clinical study for PD in 2016 and continue to invest in our technological solutions to support clinical trials in this area.

Read more

Huntington's Disease

We are a trusted imaging provider and preferred supplier for pharma and biotech, with IXICO providing advanced imaging analytics for 11 HD trials.

Read more

Multiple Sclerosis

We have been involved in MS since 2015 through our Assessa PML collaboration with big pharma.

Read more

Progressive Supranuclear Palsy

IXICO has supported clinical trials in this area since 2015 having provided advanced analytics for 5 clinical trials across 230 global sites.

Read more

Other Rare Neurological Diseases

IXICO specialises in imaging operations, data managment and analytics of rare neurological disorders, including but not limited to Huntington's Disease (HD), Progressive Supranuclear Palsy (PSP), Multiple System Atrophy (MSA), and Spinocerebellar Ataxia (SCA).

Read more